Tudor Investment Corp’s Ambrx Biopharma Inc AMAM Stock Holding History

Tudor Investment Corp’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,800	Closed	-$154K	–	2907
2023 Q4	$154K	Buy	+10,800	New	+$123K	﹤0.01%	2228
2022 Q4	–	Sell	-16,315	Closed	-$18K	–	2959
2022 Q3	$18K	Sell	16,315 -2,748	-14%	-$5.66K	﹤0.01%	2213
2022 Q2	$51K	Sell	19,063 -1,080	-5%	-$4.12K	﹤0.01%	1967
2022 Q1	$83K	Hold	20,143	–	–	﹤0.01%	1847
2021 Q4	$182K	Hold	20,143	–	–	﹤0.01%	2188
2021 Q3	$272K	Sell	20,143 -39,857	-66%	-$717K	﹤0.01%	2113
2021 Q2	$1.18M	Buy	+60,000	New	+$1.02M	0.02%	782

Tudor Investment Corp's AMAM Position: Q1 2024 in Review

Tudor Investment Corp sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 10,800 shares — an estimated $154K sold.

Tudor Investment Corp first reported a position in AMAM in Q2 2021 and held it in 7 quarters. The position peaked at $1.18M in Q2 2021. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Tudor Investment Corp reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Tudor Investment Corp sold 10,800 Ambrx Biopharma Inc shares in Q1 2024, an estimated $154K.
Tudor Investment Corp first reported a position in Ambrx Biopharma Inc in Q2 2021 and held it in 7 quarters.
Tudor Investment Corp's Ambrx Biopharma Inc position peaked at $1.18M in Q2 2021.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Tudor Investment Corp's 13F filing for Q1 2024, filed 15 May 2024.